Basit öğe kaydını göster

Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases

dc.contributor.authorYenerel, Mustafa Nuri
dc.contributor.authorYonal-Hindilerden, Ipek
dc.contributor.authorHindilerden, Fehmi
dc.contributor.authorDiz-Kucukkaya, Reyhan
dc.contributor.authorNalcaci, Meliha
dc.date.accessioned2021-03-03T10:18:41Z
dc.date.available2021-03-03T10:18:41Z
dc.date.issued2017
dc.identifier.citationHindilerden F., Yonal-Hindilerden I., Yenerel M. N. , Nalcaci M., Diz-Kucukkaya R., "Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases", TURKISH JOURNAL OF HEMATOLOGY, cilt.34, sa.1, ss.72-80, 2017
dc.identifier.issn1300-7777
dc.identifier.otherav_21e8fab9-1762-41c9-bbaa-6877078d573f
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/27815
dc.identifier.urihttps://doi.org/10.4274/tjh.2016.0086
dc.description.abstractObjective: This paper prospectively evaluates the long-term follow-up [mean +/- standard deviation (SD) duration: 89.7 +/- 19.4 months] data of 15 patients (13 females and 2 males) with refractory symptomatic immune thrombocytopenia (ITP) treated with rituximab.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectHematoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.titleRituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases
dc.typeMakale
dc.relation.journalTURKISH JOURNAL OF HEMATOLOGY
dc.contributor.departmentBakirkoy Dr. Sadi Konuk Research & Training Hospital , ,
dc.identifier.volume34
dc.identifier.issue1
dc.identifier.startpage72
dc.identifier.endpage80
dc.contributor.firstauthorID238934


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster